More articles from INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

You have access
Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease
John Doukas, Lisa Eide, Karin Stebbins, Adrienne Racanelli-Layton, Luis Dellamary, Michael Martin, Elena Dneprovskaia, Glenn Noronha, Richard Soll, Wolfgang Wrasidlo, Lisette M. Acevedo and David A. Cheresh

Journal of Pharmacology and Experimental Therapeutics March 2009, 328 (3) 758-765; DOI: https://doi.org/10.1124/jpet.108.144311
You have access
Anti-Ccl2 Spiegelmer Permits 75% Dose Reduction of Cyclophosphamide to Control Diffuse Proliferative Lupus Nephritis and Pneumonitis in MRL-Fas(lpr) Mice
Onkar Kulkarni, Dirk Eulberg, Norma Selve, Stefan Zöllner, Ramanjaneyulu Allam, Rahul D. Pawar, Stephanie Pfeiffer, Stephan Segerer, Sven Klussmann and Hans-Joachim Anders

Journal of Pharmacology and Experimental Therapeutics February 2009, 328 (2) 371-377; DOI: https://doi.org/10.1124/jpet.108.142711
You have access
Do Desipramine [10,11-Dihydro-5-[3-(methylamino) propyl]-5H-dibenz[b,f]azepine monohydrochloride] and Fluoxetine [N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-propan-1-amine] Ameliorate the Extent of Colonic Damage Induced by Acetic Acid in Rats?
Aida Ahmad Guemei, Nagwa Mahmoud Nour El Din, Azza Mohamed Baraka and Inas El Said Darwish

Journal of Pharmacology and Experimental Therapeutics December 2008, 327 (3) 846-850; DOI: https://doi.org/10.1124/jpet.108.141259
You have access
Comparison of Cigarette Smoke-Induced Acute Inflammation in Multiple Strains of Mice and the Effect of a Matrix Metalloproteinase Inhibitor on These Responses
Abigail Morris, Gillian Kinnear, Wing-Yan Heidi Wan, Daniel Wyss, Parmjit Bahra and Christopher S. Stevenson

Journal of Pharmacology and Experimental Therapeutics December 2008, 327 (3) 851-862; DOI: https://doi.org/10.1124/jpet.108.140848
You have access
Identification and Characterization of NDT 9513727 [N,N-bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse Agonist
Robbin M. Brodbeck, Daniel N. Cortright, Andrzej P. Kieltyka, Jianying Yu, Carolyn O. Baltazar, Marianne E. Buck, Robin Meade, George D. Maynard, Andrew Thurkauf, Du-Shieng Chien, Alan J. Hutchison and James E. Krause

Journal of Pharmacology and Experimental Therapeutics December 2008, 327 (3) 898-909; DOI: https://doi.org/10.1124/jpet.108.141572
You have access
A Novel CCR5-Specific Pharmacodynamic Assay in Whole Blood Using Phosphoflow Cytometry Highlights Different Ligand-Dependent Responses but Similar Properties of Antagonists in CD8⁺ and CD4⁺ T Lymphocytes
Martin E. Dahl, Amy Berson, Jose Lora and Maria Fuentes

Journal of Pharmacology and Experimental Therapeutics December 2008, 327 (3) 926-933; DOI: https://doi.org/10.1124/jpet.108.142695
You have access
Effect of Erythromycin on Biological Activities Induced by Clostridium perfringens α-Toxin
Masataka Oda, Atsushi Kihara, Hiroki Yoshioka, Yuki Saito, Naoyuki Watanabe, Kana Uoo, Masahiro Higashihara, Masahiro Nagahama, Naoki Koide, Takashi Yokochi and Jun Sakurai

Journal of Pharmacology and Experimental Therapeutics December 2008, 327 (3) 934-940; DOI: https://doi.org/10.1124/jpet.108.143677
You have access
Inhibition of Soluble Epoxide Hydrolase Does Not Protect against Endotoxin-Mediated Hepatic Inflammation
Kimberly L. Fife, YingMei Liu, Kara R. Schmelzer, Hsing-Ju Tsai, In-Hae Kim, Christophe Morisseau, Bruce D. Hammock and Deanna L. Kroetz

Journal of Pharmacology and Experimental Therapeutics December 2008, 327 (3) 707-715; DOI: https://doi.org/10.1124/jpet.108.142398
You have access
Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity
Ronald J. Hill, Karim Dabbagh, Deborah Phippard, Ching Li, Rebecca T. Suttmann, Mary Welch, Eva Papp, Kyung W. Song, Kung-ching Chang, David Leaffer, Yong-Nam Kim, Richard T. Roberts, Tanja S. Zabka, Dee Aud, Joseph Dal Porto, Anthony M. Manning, Stanford L. Peng, David M. Goldstein and Brian R. Wong

Journal of Pharmacology and Experimental Therapeutics December 2008, 327 (3) 610-619; DOI: https://doi.org/10.1124/jpet.108.139006
You have access
Characterization of N-(Adamantan-1-ylmethyl)-5-[(3R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X₇ Antagonist in Animal Models of Pain and Inflammation
Daniel C. Broom, David J. Matson, Elizabeth Bradshaw, Marianne E. Buck, Robin Meade, Susan Coombs, Michele Matchett, Kristen K. Ford, Weifeng Yu, Jun Yuan, Synthia H. Sun, Ricardo Ochoa, James E. Krause, David J. Wustrow and Daniel N. Cortright

Journal of Pharmacology and Experimental Therapeutics December 2008, 327 (3) 620-633; DOI: https://doi.org/10.1124/jpet.108.141853

Main menu

User menu

Search

More articles from INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Pages

Navigate

More Information

ASPET's Other Journals